View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Origin Pharma Packaging Expand Cleanroom Manufacturing to Meet Demand

As legislation and ethical awareness evolves, Origin Pharma Packaging has seen the demand for innovative design and production of child-safe packaging increase on a global scale.

Our new product development (NPD) team are continually investing their time and knowledge in developing commercial solutions for child-resistant compliant packaging for the UK, Europe, the US and beyond.

During the past twenty-four months, Origin Pharma Packaging has partnered custom design and manufacturing projects not compatible with the larger manufacturing sites across the Hybrid Pharma Packaging  (HP3) network. As a result, Origin has added a new cleanroom manufacturing facility to the HP3 network, located in Melton, East Yorkshire, UK.

Origin has executed a multi-million-pound investment programme at its Centre of Excellence for Pharmaceutical Packaging Design & Innovation. Installing and delivering a cleanroom production facility to ISO 7 (class 10,000) or ISO8 (class 100,000) boosting the capabilities of the existing HP3 network. The facility is equipped for the manufacture of injection moulded (IM), injection stretch blow moulded (ISBM) and injection blow moulded (IBM) parts.

Cleanroom production facility key facts:

  • Classification: ISO7/ class 10,000 to ISO8/ class 100,000
  • Compliant with ISO14644 and ISO9001-ISO 15378
  • Processes (all-electric): IM), ISBM and IBM
  • Automatic assembly

The HP3 network required the addition of this specific facility at a regional level, combining cleanroom classification, multiple ISO and good manufacturing practice (GMP) compliance, Medicines and Healthcare Products Regulatory Agency (MHRA) pursuit, European Pharmacopoeia (EUPh) compliant raw material sources, custom flexibility and integral supply chain assurance.

Due to the urgency of a sponsor project, a global pharmaceuticals manufacturing company, Origin executed and delivered the cleanroom production facility within four months. It is now fully functional, and production commenced in Q1 2018.

This white paper showcases a case study demonstrating how Origin Pharma Packaging worked in collaboration with a new pharma start-up. 
It’s very easy to go about your day-to-day life without thinking about the impact the products you buy and use have on the environment.
Child-resistant packaging is a critical component of producing and selling hazardous substances such as pharmaceuticals and toxic materials.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology